Trichomoniázis (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Trichomoniázis" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

18doi.org

2^nd place

8^th place

18worldcat.org

5^th place

22^nd place

18nih.gov

4^th place

11^th place

5archive.org

6^th place

14^th place

1mdedge.com

low place

1sekisuidiagnostics.com

low place

1medicover.hu

low place

archive.org

Schwebke JR, Burgess D. (2004. October). „Trichomoniasis.” (angol nyelven). Clin Microbiol Rev. 17 (4), 794-803. o. DOI:10.1128/CMR.17.4.794-803.2004. PMID 15489349.
Miller WC, Swygard H, Hobbs MM, Ford CA, Handcock MS, Morris M, Schmitz JL, Cohen MS, Harris KM, Udry JR. (2005. October). „The prevalence of trichomoniasis in young adults in the United States.” (angol nyelven). Sex Transm Dis. 32 (10), 593-8. o. PMID 16205299.
Mason PR, Super H, Fripp PJ (1976. 2). „Comparison of four techniques for the routine diagnosis of Trichomonas vaginalis infection”. Journal of Clinical Pathology 29 (2), 154-157. o. DOI:10.1136/jcp.29.2.154. ISSN 0021-9746. PMID 58872.
Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE (2004. 10). „Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis”. Clinical Microbiology Reviews 17 (4), 783-793. o. DOI:10.1128/cmr.17.4.783-793.2004. ISSN 0893-8512. PMID 15489348.
Brotman RM, Bradford LL, Conrad M, Gajer P, Ault K, Peralta L, Forney LJ, Carlton JM, Abdo Z, Ravel J (2012. 10). „Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women”. Sexually Transmitted Diseases 39 (10), 807-812. o. DOI:10.1097/olq.0b013e3182631c79. ISSN 0148-5717. PMID 23007708.

doi.org

dx.doi.org

Schwebke JR, Burgess D. (2004. October). „Trichomoniasis.” (angol nyelven). Clin Microbiol Rev. 17 (4), 794-803. o. DOI:10.1128/CMR.17.4.794-803.2004. PMID 15489349.
Gerd Neumann, Axel Schäfer. Mikroskopische Diagnostik in der Frauenarztpraxis, 1. kiadás, Springer-Verlag Berlin Heidelberg. DOI: 10.1007/978-3-642-20936-9 (2012). ISBN 978-3-642-20935-2
Mason PR, Super H, Fripp PJ (1976. 2). „Comparison of four techniques for the routine diagnosis of Trichomonas vaginalis infection”. Journal of Clinical Pathology 29 (2), 154-157. o. DOI:10.1136/jcp.29.2.154. ISSN 0021-9746. PMID 58872.
Borchardt KA, Zhang MZ, Shing H, Flink K (1997. 8). „A comparison of the sensitivity of the InPouch TV, Diamond's and Trichosel media for detection of Trichomonas vaginalis”. Genitourinary Medicine 73 (4), 297-298. o. DOI:10.1136/sti.73.4.297. ISSN 0266-4348. PMID 9389954.
Patel SR, Wiese W, Patel SC, Ohl C, Byrd JC, Estrada CA (2000. 1). „Systematic review of diagnostic tests for vaginal trichomoniasis”. Infectious Diseases in Obstetrics and Gynecology 8 (5-6), 248-257. o. DOI:10.1155/s1064744900000375. ISSN 1064-7449. PMID 11220487.
Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE (2004. 10). „Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis”. Clinical Microbiology Reviews 17 (4), 783-793. o. DOI:10.1128/cmr.17.4.783-793.2004. ISSN 0893-8512. PMID 15489348.
Wendel KA, Workowski KA (2007. 4). „Trichomoniasis: challenges to appropriate management”. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 44 (Suppl 3), S123-9. o. DOI:10.1086/511425. ISSN 1058-4838. PMID 17342665.
Mammen-Tobin A, Wilson JD (2005. 7). „Management of metronidazole-resistant Trichomonas vaginalis – a new approach”. International Journal of STD & AIDS 16 (7), 488-490. o. DOI:10.1258/0956462054308422. ISSN 0956-4624. PMID 16004628.
Mendling W, Weissenbacher ER, Gerber S, Prasauskas V, Grob P (2015. 10). „Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review”. Archives of Gynecology and Obstetrics 293 (3), 469-484. o. DOI:10.1007/s00404-015-3914-8. ISSN 0932-0067. PMID 26506926.
De La Hoz FJE (2019. 6). „Efficacy and tolerance of policresulen in the treatment of the genitourinary syndrome of menopause”. International Journal of Family & Community Medicine 3 (3), 132-136. o. DOI:10.15406/ijfcm.2019.03.00145. ISSN 2577-8269. „Policresulen has a selective effect on dead or pathologically altered tissues in the vagina, making them coagulate with a subsequent elimination, without affecting the healthy squamous epithelium. Its broad antimicrobial spectrum eradicates the pathogens of the vagina (bacteria, trichomonas and fungi), but increases the growth of Lactobacilli (Bacillus Döderlein) responsible for maintaining the physiological acidity of the vagina.”
Küng E, Pietrzak J, Klaus C, Walochnik J (2016. 1). „In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis”. International Journal of Antimicrobial Agents 47 (3), 232-234. o. DOI:10.1016/j.ijantimicag.2015.12.010. ISSN 0924-8579. PMID 26899578.
Brotman RM, Bradford LL, Conrad M, Gajer P, Ault K, Peralta L, Forney LJ, Carlton JM, Abdo Z, Ravel J (2012. 10). „Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women”. Sexually Transmitted Diseases 39 (10), 807-812. o. DOI:10.1097/olq.0b013e3182631c79. ISSN 0148-5717. PMID 23007708.
Mercer F, Johnson PJ (2018. 6). „Trichomonas vaginalis: Pathogenesis, symbiont interactions, and host cell immune responses”. Trends in Parasitology 34 (8), 683-693. o. DOI:10.1016/j.pt.2018.05.006. ISSN 1471-4922. PMID 30056833.
Pavić R, Stojković L (1983. 1). „Vaccination with SolcoTrichovac. Immunological aspects of a new approach for therapy and prophylaxis of trichomoniasis in women”. Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2), 27–38. o. DOI:10.1159/000269590. ISSN 0017-6001. PMID 6629132.
de Weck A (1984. 1). „An explanation of the mode of action of Gynatren/SolcoTrichovac based on immunological considerations”. Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3), 25–28. o. DOI:10.1159/000269922. ISSN 0017-6001. PMID 6537384.
Spiegel CA.szerk.: Honigberg BM: Microflora associated with Trichomonas vaginalis and vaccination against vaginal trichomoniasis, Trichomonads parasitic in humans. Springer, New York, NY, 213–224. o.. DOI: 10.1007/978-1-4612-3224-7_10 (1990). ISBN 978-1-4612-7922-8
Goisis M, Magliano E, Goisis F (1983. 1). „Effects of vaccination with SolcoTrichovac on the vaginal flora and the morphology of the Doederlein bacilli”. Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2), 56–63. o. DOI:10.1159/000269598. ISSN 0017-6001. PMID 6629136.
Harris JRW (1984. 1). „Double-blind comparative study of Trichomonas vaginalis infection: SolcoTrichovac versus placebo”. Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3), 44–49. o. DOI:10.1159/000269925. ISSN 0017-6001. PMID 6399488.

mdedge.com

cdn.mdedge.com

Jane Schwebke (2012. 9). „Trichomonas: clinical analysis of a highly prevalent and misdiagnosed infection”. OBG Management 24 (9, Suppl.), S1–S4. o. ISSN 1044-307X.

medicover.hu

Szexuálisan terjedő betegségek (STD) laboratóriumi tesztjei nőknek nőgyógyászati mintavétellel. Medicover Zrt.. (Hozzáférés: 2021. március 9.)

nih.gov

pubmed.ncbi.nlm.nih.gov

Schwebke JR, Burgess D. (2004. October). „Trichomoniasis.” (angol nyelven). Clin Microbiol Rev. 17 (4), 794-803. o. DOI:10.1128/CMR.17.4.794-803.2004. PMID 15489349.
Miller WC, Swygard H, Hobbs MM, Ford CA, Handcock MS, Morris M, Schmitz JL, Cohen MS, Harris KM, Udry JR. (2005. October). „The prevalence of trichomoniasis in young adults in the United States.” (angol nyelven). Sex Transm Dis. 32 (10), 593-8. o. PMID 16205299.
Mason PR, Super H, Fripp PJ (1976. 2). „Comparison of four techniques for the routine diagnosis of Trichomonas vaginalis infection”. Journal of Clinical Pathology 29 (2), 154-157. o. DOI:10.1136/jcp.29.2.154. ISSN 0021-9746. PMID 58872.
Borchardt KA, Zhang MZ, Shing H, Flink K (1997. 8). „A comparison of the sensitivity of the InPouch TV, Diamond's and Trichosel media for detection of Trichomonas vaginalis”. Genitourinary Medicine 73 (4), 297-298. o. DOI:10.1136/sti.73.4.297. ISSN 0266-4348. PMID 9389954.
Patel SR, Wiese W, Patel SC, Ohl C, Byrd JC, Estrada CA (2000. 1). „Systematic review of diagnostic tests for vaginal trichomoniasis”. Infectious Diseases in Obstetrics and Gynecology 8 (5-6), 248-257. o. DOI:10.1155/s1064744900000375. ISSN 1064-7449. PMID 11220487.
Kimberly A. Workowski, Gail A. Bolan (2015. 6). „Sexually Transmitted Diseases Treatment Guidelines, 2015”. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly report 64 (RR-03), 1-137. o. ISSN 1057-5987. PMID 26042815.
Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE (2004. 10). „Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis”. Clinical Microbiology Reviews 17 (4), 783-793. o. DOI:10.1128/cmr.17.4.783-793.2004. ISSN 0893-8512. PMID 15489348.
Wendel KA, Workowski KA (2007. 4). „Trichomoniasis: challenges to appropriate management”. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 44 (Suppl 3), S123-9. o. DOI:10.1086/511425. ISSN 1058-4838. PMID 17342665.
Mammen-Tobin A, Wilson JD (2005. 7). „Management of metronidazole-resistant Trichomonas vaginalis – a new approach”. International Journal of STD & AIDS 16 (7), 488-490. o. DOI:10.1258/0956462054308422. ISSN 0956-4624. PMID 16004628.
Mendling W, Weissenbacher ER, Gerber S, Prasauskas V, Grob P (2015. 10). „Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review”. Archives of Gynecology and Obstetrics 293 (3), 469-484. o. DOI:10.1007/s00404-015-3914-8. ISSN 0932-0067. PMID 26506926.
Küng E, Pietrzak J, Klaus C, Walochnik J (2016. 1). „In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis”. International Journal of Antimicrobial Agents 47 (3), 232-234. o. DOI:10.1016/j.ijantimicag.2015.12.010. ISSN 0924-8579. PMID 26899578.
Brotman RM, Bradford LL, Conrad M, Gajer P, Ault K, Peralta L, Forney LJ, Carlton JM, Abdo Z, Ravel J (2012. 10). „Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women”. Sexually Transmitted Diseases 39 (10), 807-812. o. DOI:10.1097/olq.0b013e3182631c79. ISSN 0148-5717. PMID 23007708.
Mercer F, Johnson PJ (2018. 6). „Trichomonas vaginalis: Pathogenesis, symbiont interactions, and host cell immune responses”. Trends in Parasitology 34 (8), 683-693. o. DOI:10.1016/j.pt.2018.05.006. ISSN 1471-4922. PMID 30056833.
Pavić R, Stojković L (1983. 1). „Vaccination with SolcoTrichovac. Immunological aspects of a new approach for therapy and prophylaxis of trichomoniasis in women”. Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2), 27–38. o. DOI:10.1159/000269590. ISSN 0017-6001. PMID 6629132.
de Weck A (1984. 1). „An explanation of the mode of action of Gynatren/SolcoTrichovac based on immunological considerations”. Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3), 25–28. o. DOI:10.1159/000269922. ISSN 0017-6001. PMID 6537384.
Goisis M, Magliano E, Goisis F (1983. 1). „Effects of vaccination with SolcoTrichovac on the vaginal flora and the morphology of the Doederlein bacilli”. Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2), 56–63. o. DOI:10.1159/000269598. ISSN 0017-6001. PMID 6629136.
Harris JRW (1984. 1). „Double-blind comparative study of Trichomonas vaginalis infection: SolcoTrichovac versus placebo”. Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3), 44–49. o. DOI:10.1159/000269925. ISSN 0017-6001. PMID 6399488.

ncbi.nlm.nih.gov

Kimberly A. Workowski, Gail A. Bolan (2015. 6). „Sexually Transmitted Diseases Treatment Guidelines, 2015”. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly report 64 (RR-03), 1-137. o. ISSN 1057-5987. PMID 26042815.

sekisuidiagnostics.com

OSOM Trichomonas Test. A rapid test for the detection of Trichomonas vaginalis. Documentation CLSI: Sample Procedure. Sekisui Diagnostics, LLC. (Hozzáférés: 2021. március 9.)

worldcat.org

Jane Schwebke (2012. 9). „Trichomonas: clinical analysis of a highly prevalent and misdiagnosed infection”. OBG Management 24 (9, Suppl.), S1–S4. o. ISSN 1044-307X.
Mason PR, Super H, Fripp PJ (1976. 2). „Comparison of four techniques for the routine diagnosis of Trichomonas vaginalis infection”. Journal of Clinical Pathology 29 (2), 154-157. o. DOI:10.1136/jcp.29.2.154. ISSN 0021-9746. PMID 58872.
Borchardt KA, Zhang MZ, Shing H, Flink K (1997. 8). „A comparison of the sensitivity of the InPouch TV, Diamond's and Trichosel media for detection of Trichomonas vaginalis”. Genitourinary Medicine 73 (4), 297-298. o. DOI:10.1136/sti.73.4.297. ISSN 0266-4348. PMID 9389954.
Patel SR, Wiese W, Patel SC, Ohl C, Byrd JC, Estrada CA (2000. 1). „Systematic review of diagnostic tests for vaginal trichomoniasis”. Infectious Diseases in Obstetrics and Gynecology 8 (5-6), 248-257. o. DOI:10.1155/s1064744900000375. ISSN 1064-7449. PMID 11220487.
Kimberly A. Workowski, Gail A. Bolan (2015. 6). „Sexually Transmitted Diseases Treatment Guidelines, 2015”. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly report 64 (RR-03), 1-137. o. ISSN 1057-5987. PMID 26042815.
Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE (2004. 10). „Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis”. Clinical Microbiology Reviews 17 (4), 783-793. o. DOI:10.1128/cmr.17.4.783-793.2004. ISSN 0893-8512. PMID 15489348.
Wendel KA, Workowski KA (2007. 4). „Trichomoniasis: challenges to appropriate management”. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 44 (Suppl 3), S123-9. o. DOI:10.1086/511425. ISSN 1058-4838. PMID 17342665.
Mammen-Tobin A, Wilson JD (2005. 7). „Management of metronidazole-resistant Trichomonas vaginalis – a new approach”. International Journal of STD & AIDS 16 (7), 488-490. o. DOI:10.1258/0956462054308422. ISSN 0956-4624. PMID 16004628.
Mendling W, Weissenbacher ER, Gerber S, Prasauskas V, Grob P (2015. 10). „Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review”. Archives of Gynecology and Obstetrics 293 (3), 469-484. o. DOI:10.1007/s00404-015-3914-8. ISSN 0932-0067. PMID 26506926.
De La Hoz FJE (2019. 6). „Efficacy and tolerance of policresulen in the treatment of the genitourinary syndrome of menopause”. International Journal of Family & Community Medicine 3 (3), 132-136. o. DOI:10.15406/ijfcm.2019.03.00145. ISSN 2577-8269. „Policresulen has a selective effect on dead or pathologically altered tissues in the vagina, making them coagulate with a subsequent elimination, without affecting the healthy squamous epithelium. Its broad antimicrobial spectrum eradicates the pathogens of the vagina (bacteria, trichomonas and fungi), but increases the growth of Lactobacilli (Bacillus Döderlein) responsible for maintaining the physiological acidity of the vagina.”
Küng E, Pietrzak J, Klaus C, Walochnik J (2016. 1). „In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis”. International Journal of Antimicrobial Agents 47 (3), 232-234. o. DOI:10.1016/j.ijantimicag.2015.12.010. ISSN 0924-8579. PMID 26899578.
Brotman RM, Bradford LL, Conrad M, Gajer P, Ault K, Peralta L, Forney LJ, Carlton JM, Abdo Z, Ravel J (2012. 10). „Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women”. Sexually Transmitted Diseases 39 (10), 807-812. o. DOI:10.1097/olq.0b013e3182631c79. ISSN 0148-5717. PMID 23007708.
Mercer F, Johnson PJ (2018. 6). „Trichomonas vaginalis: Pathogenesis, symbiont interactions, and host cell immune responses”. Trends in Parasitology 34 (8), 683-693. o. DOI:10.1016/j.pt.2018.05.006. ISSN 1471-4922. PMID 30056833.
Újhelyi Károly, Philipp György, Plank György, Sági Tamás (1973). „A trichomonas syndroma”. Magyar Nőorvosok Lapja 36, 433–442. o. ISSN 0025-021X.
Pavić R, Stojković L (1983. 1). „Vaccination with SolcoTrichovac. Immunological aspects of a new approach for therapy and prophylaxis of trichomoniasis in women”. Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2), 27–38. o. DOI:10.1159/000269590. ISSN 0017-6001. PMID 6629132.
de Weck A (1984. 1). „An explanation of the mode of action of Gynatren/SolcoTrichovac based on immunological considerations”. Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3), 25–28. o. DOI:10.1159/000269922. ISSN 0017-6001. PMID 6537384.
Goisis M, Magliano E, Goisis F (1983. 1). „Effects of vaccination with SolcoTrichovac on the vaginal flora and the morphology of the Doederlein bacilli”. Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2), 56–63. o. DOI:10.1159/000269598. ISSN 0017-6001. PMID 6629136.
Harris JRW (1984. 1). „Double-blind comparative study of Trichomonas vaginalis infection: SolcoTrichovac versus placebo”. Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3), 44–49. o. DOI:10.1159/000269925. ISSN 0017-6001. PMID 6399488.